While induction of PD-L1 by APOBEC3A would suggest a mechanism of immune evasion and resistance, such an effect should theoretically lead to increased sensitivity to CPI, which was not seen in this patient’s resistant tumor. Here, APOBEC3A is linked to neoplasm.